IE62095B1 - Pharmaceutical formulations for parenteral use - Google Patents

Pharmaceutical formulations for parenteral use


Publication number
IE62095B1 IE81089A IE81089A IE62095B1 IE 62095 B1 IE62095 B1 IE 62095B1 IE 81089 A IE81089 A IE 81089A IE 81089 A IE81089 A IE 81089A IE 62095 B1 IE62095 B1 IE 62095B1
Prior art keywords
pharmaceutical formulations
parenteral use
Prior art date
Application number
Other versions
IE890810L (en
Nicholas S Bodor
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/174,945 priority Critical patent/US4983586A/en
Application filed by Univ Florida filed Critical Univ Florida
Publication of IE890810L publication Critical patent/IE890810L/en
Publication of IE62095B1 publication Critical patent/IE62095B1/en


IE81089A 1987-12-30 1989-03-14 Pharmaceutical formulations for parenteral use IE62095B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/174,945 US4983586A (en) 1987-12-30 1988-03-29 Pharmaceutical formulations for parenteral use

Publications (2)

Publication Number Publication Date
IE890810L IE890810L (en) 1989-09-29
IE62095B1 true IE62095B1 (en) 1994-12-14



Family Applications (1)

Application Number Title Priority Date Filing Date
IE81089A IE62095B1 (en) 1987-12-30 1989-03-14 Pharmaceutical formulations for parenteral use

Country Status (4)

Country Link
JP (1) JP2643426B2 (en)
CA (1) CA1336498C (en)
IE (1) IE62095B1 (en)
ZA (1) ZA8902315B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287775B6 (en) * 1998-02-05 2011-09-05 Novartis Ag Pharmaceutical formulation containing epothilone, infusion solution and use of pharmaceutical formulation
NZ540484A (en) * 2002-12-02 2008-03-28 Bharat Serums & Vaccines Ltd Stable, clear, aqueous ifosfamide compositions for parenteral administration and a process for their preparation
EP2301549A1 (en) * 2003-04-18 2011-03-30 Advanced Medicine Research Institute Remedies for diseases to be applied to eye
DE102004011512A1 (en) 2004-03-08 2005-09-22 Boehringer Ingelheim Vetmedica Gmbh A pharmaceutical preparation comprising pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
JP4956981B2 (en) * 2005-01-05 2012-06-20 大正製薬株式会社 Oxymetazoline-containing aqueous composition
US8318712B2 (en) * 2006-01-06 2012-11-27 Intervet International B.V. Concentrated liquid thyroid hormone composition
UA95310C2 (en) * 2006-10-20 2011-07-25 Айкос Корпорейшен Composition containing chkl inhibitor and cyclodextrin for the treatment of cancer
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
CN101961311B (en) * 2010-09-21 2012-11-21 中山大学 5alpha-androstane (alkyl)-3beta,5,6beta-triol injection and preparation method thereof
EP3167876A1 (en) 2012-03-15 2017-05-17 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
AU2014292086B2 (en) 2013-07-19 2019-08-08 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
CA2930033A1 (en) 2013-12-04 2015-06-11 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan

Also Published As

Publication number Publication date
JP2643426B2 (en) 1997-08-20
IE890810L (en) 1989-09-29
ZA8902315B (en) 1990-12-28
JPH029825A (en) 1990-01-12
CA1336498C (en) 1995-08-01

Similar Documents

Publication Publication Date Title
GB2222772B (en) Pharmaceutical compositions
CZ80395A3 (en) Pharmaceutical preparation
PL301579A1 (en) Pharmaceutical preparation
IL83897D0 (en) Pharmaceutical formulations
YU47989A (en) Hypoglicemic thiazolidindion derivatives
GB2219940B (en) Pharmaceutical compositions
CS403391A3 (en) Pharmaceutical
IE921472A1 (en) Pharmaceutical formulations
GB2218905B (en) Controlled release pharmaceutical
ZA9003181B (en) Pharmaceutical formulation
AU4341789A (en) Pharmaceutical formulations
GB8905443D0 (en) Dihalogrnobenzene derivatives
GB9022788D0 (en) Pharmaceutical formulations
ZA9102411B (en) Pharmaceutical formulations
ZA9102793B (en) Pharmaceutical formulations
AU3159993A (en) Drug formulations for parenteral use
IL91836D0 (en) Granular pharmaceutical formulations
IE61616B1 (en) Pharmaceutical compositions
ZA9008157B (en) Pharmaceutical phenylpyridone derivatives
ZA8802167B (en) Pharmaceutical formulations
HK85196A (en) Pharmaceutical formulations
GB8819477D0 (en) Medicaments
GB8707421D0 (en) Pharmaceutical formulations
HU894130D0 (en) 13-alkyl-11-beta-phenyl-gonane derivatives
HK125293A (en) Oral preparations

Legal Events

Date Code Title Description
DD9A Application for amendment of patent specification now open to opposition (sect. 38)
MK9A Patent expired